- βInsulin pumps significantly reduced parent-reported behavior problems in children after 4 months compared to daily injections
- βPump users achieved a clinically meaningful 0.6% lower HbA1c than injection users at 4 months, closer to ADA pediatric targets
- βThe 2-year follow-up provides rare long-term data, revealing that pump therapy alone does not sustain comprehensive neuropsychological benefits
| Country | Australia |
| Journal | Archives of disease in childhood |
| Year | 2024 |
| Authors | O'Connell, Northam, Brown |
| PMID | 38237958 |
Australian Study: Do Insulin Pumps Improve Behavior and Blood Sugar in Kids with Type 1 Diabetes?
A study from Australia offers a rare long-term look at whether insulin pumps β not just blood sugar control β can also improve the emotional and mental well-being of children living with type 1 diabetes (T1D). Researchers at The Royal Children's Hospital Melbourne conducted one of the most rigorous trials to date on this question, with findings that are both encouraging and thought-provoking for American families navigating the same decisions.
What the Researchers Did
Scientists enrolled 101 children and adolescents aged 7 to 15 years with type 1 diabetes across two major Australian pediatric centers. Participants were randomly assigned to either begin using a continuous subcutaneous insulin infusion device β commonly known as an insulin pump β or to continue multiple daily injections (MDI). Researchers tracked not only blood sugar levels, but also behavior, mood, and cognitive function over four months. After the initial trial, children in the injection group switched to pumps, and all participants were followed for an additional two years.
Key Findings
After four months, children using insulin pumps showed meaningful advantages in two important areas:
- Behavior: Parents reported significantly fewer behavioral problems in children using pumps compared to those on injections (a moderate effect size of Cohen's d = 0.41).
- Blood Sugar Control (HbA1c): Pump users had HbA1c levels that were 0.6% lower than injection users β a clinically meaningful difference. In practical terms, this could represent the difference between an HbA1c of 8.0% and 7.4%, which aligns more closely with the American Diabetes Association's (ADA) target of below 7.0β7.5% for most children with T1D.
However, mood and cognitive outcomes improved in both groups over four months, with no significant difference between pump and injection users in those areas. And by the two-year follow-up, the behavioral and blood sugar advantages of pump therapy had largely leveled off, with no significant differences between groups compared to where they started.
Understanding the Blood Sugar Numbers
The study reported an HbA1c improvement of 7 mmol/mol, which equals approximately 0.6% in the percentage units used in the United States. If a child's HbA1c was 63 mmol/mol (about 7.9% in US units), pump therapy brought it closer to 56 mmol/mol (7.3%) β a meaningful step toward the ADA's pediatric guideline of under 7.5%.
Why This Matters for US Patients
Insulin pump use is common in the United States, with many American families choosing pumps hoping for benefits beyond blood sugar control β including reduced daily burden, better mood, and fewer school or behavioral challenges. This Australian study, conducted in a healthcare system with strong pediatric diabetes infrastructure similar to leading US children's hospitals, provides important context:
- Pumps do offer short-term benefits for behavior and HbA1c, which could be especially valuable during key developmental years.
- The emotional and cognitive benefits many families hope for may come from overall diabetes support β not the pump technology alone.
- About 21% of children in the study discontinued pump use by two years, a reminder that pump therapy requires commitment and isn't the right fit for every family.
- American families considering pumps should discuss realistic expectations with their pediatric endocrinologist, especially regarding long-term neuropsychological outcomes.
The Bottom Line
Insulin pumps can give children with type 1 diabetes a meaningful early advantage in behavior and blood sugar management, but they are not a comprehensive solution for the psychological challenges of living with T1D. Combined support β including mental health resources, diabetes education, and family counseling β remains essential alongside any device choice.
Source: O'Connell M, Northam E, Brown J. "Does insulin pump therapy offer benefits for behaviour, mood, cognition and HbA1c in children and adolescents with type 1 diabetes? A randomised controlled trial with observational follow-up." Archives of Disease in Childhood, 2024. PMID: 38237958. DOI: 10.1136/archdischild-2023-326007